Suppr超能文献

膀胱癌肌层浸润患者隐匿性淋巴结转移:新辅助化疗加膀胱切除术与单纯膀胱切除术的发生率。

Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone.

机构信息

Department of Urology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

出版信息

BJU Int. 2014 Jul;114(1):67-74. doi: 10.1111/bju.12447. Epub 2014 Jan 17.

Abstract

OBJECTIVE

To investigate the effect of neoadjuvant chemotherapy (NAC) on the incidence of lymph node (LN) metastases in clinically node-negative (cN0) patients with carcinoma invading the bladder muscle (MIBC).

PATIENTS AND METHODS

Between 1990 and 2012, 828 consecutive patients underwent radical cystectomy (RC) with extended pelvic LN dissection (ePLND), of whom 441 had cT2-4N0M0 stage disease. A total of 83 patients received NAC then underwent RC and 358 patients underwent RC only. The ePLND template and the indication for NAC remained the same during the study period. The incidence of occult LN metastases was compared between the groups. Unadjusted and adjusted odds ratios (ORs) were calculated to investigate the influence of NAC, cT stage, gender and the preoperative staging technique used (computed tomography [CT] or positron emission tomography/CT) on the occurrence of LN metastases. Overall survival (OS) and disease-specific survival were analysed using the Kaplan-Meier method.

RESULTS

Patients in the NAC group more often had locally advanced MIBC than patients in the non-NAC group (cT3-4: 88.0 vs 30.2%). In the NAC group, 19.3% of patients had LN metastases vs 28.5% of the patients in the non-NAC group (P = 0.099). In the patients with cT3-4 disease, the occurrence of LN metastases was significantly lower in the NAC group than in the non-NAC group (21.9 vs 40.7%, respectively, P = 0.002). In multivariable analysis, adjusting for cT stage, gender and staging method, NAC was independently associated with a lower likelihood of LN metastases (OR: 0.41, 95% CI 0.21-0.79; P = 0.008). Among the patients with cT3-4 disease, the median OS was significantly longer in the NAC group than in the non-NAC group (68.0 vs 23.0 months, P = 0.047) CONCLUSION: These data suggest that, along with a downstaging effect on the primary bladder tumour, NAC is associated with a lower incidence of occult LN metastases at the time of RC.

摘要

目的

探讨新辅助化疗(NAC)对浸润性膀胱癌肌层(MIBC)临床淋巴结阴性(cN0)患者淋巴结(LN)转移发生率的影响。

患者与方法

1990 年至 2012 年间,828 例连续接受根治性膀胱切除术(RC)联合广泛盆腔淋巴结清扫术(ePLND)的患者,其中 441 例为 cT2-4N0M0 期疾病。共有 83 例患者接受 NAC 后行 RC,358 例患者仅行 RC。研究期间,PLND 模板和 NAC 的适应证保持不变。比较两组隐匿性 LN 转移的发生率。采用未调整和调整的优势比(OR)来研究 NAC、cT 分期、性别以及术前分期技术(计算机断层扫描[CT]或正电子发射断层扫描/CT)对 LN 转移发生的影响。采用 Kaplan-Meier 法分析总生存(OS)和疾病特异性生存。

结果

NAC 组患者的局部晚期 MIBC 发生率高于非 NAC 组(cT3-4:88.0%比 30.2%)。NAC 组中有 19.3%的患者发生 LN 转移,而非 NAC 组中则有 28.5%(P=0.099)。在 cT3-4 疾病患者中,NAC 组的 LN 转移发生率明显低于非 NAC 组(分别为 21.9%和 40.7%,P=0.002)。多变量分析显示,在调整 cT 分期、性别和分期方法后,NAC 与 LN 转移的可能性降低独立相关(OR:0.41,95%CI 0.21-0.79;P=0.008)。在 cT3-4 疾病患者中,NAC 组的中位 OS 明显长于非 NAC 组(68.0 比 23.0 个月,P=0.047)。

结论

这些数据表明,除了原发膀胱癌降期作用外,NAC 还与 RC 时隐匿性 LN 转移发生率降低相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验